ZUNHAYRE

Serial Number 98450533
Registration 7798467
700

Registration Progress

Application Filed
Mar 14, 2024
Under Examination
Approved for Publication
Apr 1, 2025
Published for Opposition
Apr 1, 2025
Registered
May 20, 2025

Basic Information

Serial Number
98450533
Registration Number
7798467
Filing Date
March 14, 2024
Registration Date
May 20, 2025
Published for Opposition
April 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 20, 2025
Registration
Registered
Classes
005 042 044

Rights Holder

Verona Pharma PLC

84
Address
One Central Square
Cardiff CF101FS
GB

Ownership History

Verona Pharma PLC

Original Applicant
84
Cardiff GB

Verona Pharma PLC

Owner at Publication
84
Cardiff GB

Verona Pharma PLC

Original Registrant
84
Cardiff GB

Legal Representation

Attorney
John Mueller
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-20)
R.PRA May 20, 2031 2143 days Critical No
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2025-05-20)
R.PRA May 20, 2035 3604 days Critical No
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-20) on May 20, 2031 (2143 days)

Application History

24 events
Date Code Type Description
May 20, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 11, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 24, 2025 ALIE A ASSIGNED TO LIE
Jan 24, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 21, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 21, 2024 CNSL R SUSPENSION LETTER WRITTEN
Aug 21, 2024 GNSL F LETTER OF SUSPENSION E-MAILED
Aug 20, 2024 DOCK D ASSIGNED TO EXAMINER
Aug 7, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 19, 2024 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 14, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 042
Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 044
Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Active Deadlines

Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-20)
Due: May 20, 2031
Grace Period Until: Nov 20, 2031
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2025-05-20)
Due: May 20, 2035
Grace Period Until: Nov 20, 2035

Classification

International Classes
005 042 044